GENMAB A/S's ticker is GMAB and the CUSIP is 372303206. A total of 197 filers reported holding GENMAB A/S in Q3 2020. The put-call ratio across all filers is 0.36 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $12,000 | -7.7% | 355 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $13,000 | -23.5% | 355 | -15.5% | 0.00% | -33.3% |
| Q4 2021 | $17,000 | -5.6% | 420 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $18,000 | +28.6% | 420 | +18.3% | 0.00% | 0.0% |
| Q2 2021 | $14,000 | +16.7% | 355 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $12,000 | -14.3% | 355 | 0.0% | 0.00% | -25.0% |
| Q4 2020 | $14,000 | +7.7% | 355 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $13,000 | -55.2% | 355 | -58.5% | 0.00% | -63.6% |
| Q2 2020 | $29,000 | +866.7% | 855 | +612.5% | 0.01% | +1000.0% |
| Q1 2020 | $3,000 | – | 120 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 242,848 | $9,169,940 | 3.80% |
| Capricorn Fund Managers Ltd | 110,643 | $4,177,880 | 1.28% |
| Arlington Capital Management, Inc. | 35,591 | $1,343,916 | 1.26% |
| XY Capital Ltd | 76,884 | $2,903,140 | 1.13% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 88,000 | $3,322,880 | 0.93% |
| TORRAY INVESTMENT PARTNERS LLC | 110,807 | $4,184,072 | 0.75% |
| Hardman Johnston Global Advisors LLC | 585,139 | $22,094,849 | 0.72% |
| Yorktown Management & Research Co Inc | 16,600 | $626,816 | 0.68% |
| First Light Asset Management, LLC | 160,025 | $6,042,544 | 0.54% |
| MIRABELLA FINANCIAL SERVICES LLP | 28,260 | $2,505,855 | 0.38% |